Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The ...
Monogram Technologies announced that the U.S. Food and Drug Administration has granted 510(k) clearance for its Monogram mBos TKA System. This ...
On Monday, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Monogram Technologies Inc.’s (NASDAQ:MGRM ...
Monogram Technologies earned FDA 510(k) clearance for its Monogram mBôs robot, according to a March 17 news release. The ...
Market the Monogram mBôs TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).The Company is Preparing for Commercialization and Evaluating Strategies ...
Monogram Technologies (Nasdaq:MGRM) announced today that it received FDA 510(k) clearance for its mBôs total knee ...
TipRanks on MSN16h
Monogram Orthopaedics Gains FDA Clearance for TKA SystemMonogram Orthopaedics Inc ( ($MGRM) ) has issued an update. On March 17, 2025, Monogram Technologies Inc. announced that it received FDA 510(k) ...
All Penny Stocks (English) on MSN15h
FDA 510(k) Clearance Already Has This Micro Cap Off To The RacesA New York-based healthcare company is already turning heads during Monday’s premarket hours after it was announced that the ...
Enrollment complete in Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism; topline results on track for Q3 2025. MBX 1416 Phase 2 trial in patients with post-bariatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback